International Journal of Genomics

International Journal of Genomics / 2009 / Article

Research Article | Open Access

Volume 2009 |Article ID 782924 |

William A. Bryant, Preben Krabben, Frank Baganz, Yuhong Zhou, John M. Ward, "The Analysis of Multiple Genome Comparisons in Genus Escherichia and Its Application to the Discovery of Uncharacterised Metabolic Genes in Uropathogenic Escherichia coli CFT073", International Journal of Genomics, vol. 2009, Article ID 782924, 8 pages, 2009.

The Analysis of Multiple Genome Comparisons in Genus Escherichia and Its Application to the Discovery of Uncharacterised Metabolic Genes in Uropathogenic Escherichia coli CFT073

Academic Editor: Graziano Pesole
Received01 Apr 2009
Revised27 Aug 2009
Accepted02 Nov 2009
Published02 Mar 2010


A survey of a complete gene synteny comparison has been carried out between twenty fully sequenced strains from the genus Escherichia with the aim of finding yet uncharacterised genes implicated in the metabolism of uropathogenic strains of E. coli (UPEC). Several sets of adjacent colinear genes have been identified which are present in all four UPEC included in this study (CFT073, F11, UTI89, and 536), annotated with putative metabolic functions, but are not found in any other strains considered. An operon closely homologous to that encoding the L-sorbose degradation pathway in Klebsiella pneumoniae has been identified in E. coli CFT073; this operon is present in all of the UPEC considered, but only in 7 of the other 16 strains. The operon's function has been confirmed by cloning the genes into E. coli DH5 and testing for growth on L-sorbose. The functional genomic approach combining in silico and in vitro work presented here can be used as a basis for the discovery of other uncharacterised genes contributing to bacterial survival in specific environments.

1. Introduction

Uropathogenic E. coli (UPEC) are the causal agents of 80% of all community-acquired urinary tract infections (UTIs) [1]. The ability of UPEC to colonise the urinary tract has been studied in depth in terms of virulence factors such as pili and hemolysins [2]; however, the ability to utilise the metabolites available in this environment has not been fully investigated to date. While studies of growth rates in urine have been conducted (for instance by Gordon and Riley [3]), it has never been established exactly what is used as the primary carbon source (or if there is a single one) for growth of UPEC, and which genes enable the utilisation of this carbon source. There has been discussion of metabolic genes contributing to uropathogenicity, considering two UPEC: CFT073 and 536 [4]. D-serine has been posited as a potential carbon and nitrogen source due to the presence of D-serine catabolic genes in these 2 UPEC, though the requirement for these genes or their involvement in the course of a UTI has yet to be investigated.

The use of multiple genome analysis in research has been reviewed elsewhere [5], and several tools for genome comparisons are available, as well as software applications for their analysis. The most prominent tool is BLAST [6] for whole genome analyses. The set of genus Escherichia genome sequences has already been used to compare regulatory networks [7] and to investigate the genetic basis of pathogenesis in enterotoxigenic E. coli [8]. Sequencing projects (such as [4, 9]) have used up to three complete genome sequences for genomic comparisons, though this is only a small subset of the Escherichia genome sequences currently available. Recently Rasko et al. [10] have used a BLAST score ratio (BSR) technique to compare the gene contents of 17 E. coli genome sequences which has identified fewer pathovar-specific genes than might be expected.

The potential for taking advantage of the large number of already available and imminent genome sequences in the genus Escherichia is great, when combined with well-targeted experimentation. While there is no certainty from purely computational approaches that a gene is necessary or helpful in a particular environment, its presence in bacteria which thrive in that environment and its absence in bacteria which do not represent evidence for pressure to retain the gene, therefore, its function aids the persistence of the bacteria in that niche. In this study the genome sequence of E. coli CFT073 has been compared to 19 other complete genome sequences of bacteria of the genus Escherichia using a synteny approach to infer which genes are present in or absent from the other strains. Table 1 shows a list of these strains which includes four UPEC and three Shigella strains.

Strain Type Sorbose operon Source/Accession number

CFT073 UPEC (uropathogenic) + AE014075
F11 UPEC + AAJU00000000
536 UPEC + CP000247
UTI89 UPEC + CP000243

042 EAEC (enteroaggregative) Sanger Center
B7A ETEC (enterotoxigenic) AAJT00000000
E24377A ETEC CP000800

B171 EPEC (enteropathogenic) AAJX00000000
E22 EPEC AAJV00000000
E2348 EPEC Sanger Center
E110019 EPEC AAJW00000000

53638 EIEC (enteroinvasive) AAKB00000000
MG1655 Commensal (Gastrointestinal tract) U00096
HS Commensal (Gastrointestinal tract) CP000802

SMS-3-5 Environmental + CP000970
O157:H7 str. Sakai EHEC (enterohaemorrhagic) + BA000007
O157:H7 EDL933 EHEC + AE005174

Shigella sonnei 53G Bacillary Dysentery + Sanger Center
Shigella flexneri 2a str. 301 Bacillary Dysentery + AE005674
Shigella dysenteriae Sd197 Bacillary Dysentery + CP000034

Genes in CFT073 which according to their GenBank entries [11] are metabolic genes, but which do not have a specific functional assignment (e.g., gene c4985 is annotated as “Putative sorbose PTS component”), or genes of unknown function which form sets of adjacent colinear genes with those partially characterised metabolic genes, have been investigated to determine their relative occurrences in UPEC and the other strains. Some of those sets of genes more often found in UPEC than the other strains used in this study have been investigated to further elucidate their function.

One putative operon has been experimentally verified as an L-sorbose utilisation operon, after having been identified as being present more frequently in UPEC than in the other strains considered. Lehmacher and Bockemühl [12] showed in a study of 266 strains from the collection of the Institut für Hygiene und Umwelt that L-sorbose utilisation varies widely over differing pathotypes of E. coli and Shigella, from 14 of the 15 E. coli isolates associated with neonatal meningitis to a complete lack of utilisation by Shigella (of the 26 tested in the study). Although no UPEC were included, 67% of the EPEC and EAEC strains tested utilised L-sorbose.

2. Materials and Methods

2.1. Multiple Genome Comparisons

The CFT073 genome [9] was compared gene-by-gene with the genomes of the nineteen other strains listed in Table 1 using TBLASTN [6], and a synteny result was obtained by manual inspection of each individual gene-nucleotide comparison. Homology as a percentage identity from TBLASTN was combined with the position and homology of nearest neighbours and overall position in the genome to infer synteny conservation. The use of BLAST scores to determine gene conservation is well established (such as the BSR technique [10]), and this process was refined by adding a neighbour-dependent analysis to determine gene synteny. For sets of two or more genes in a similar position on two genomes, retention of function of each gene was inferred by identity with a cut-off of 90% over the whole length of each gene. Single genes in similar positions on the two genomes were inferred as conserved only if their mutual identity was above 95% over their whole length.

MG1655 does not grow in urine, whereas CFT073 does [13]. Some metabolic genes in CFT073 that are not present in MG1655 may confer a fitness advantage in the urinary tract due to better ability to use available substrates for growth. Genes present in CFT073 but not in MG1655 were therefore studied to look for such metabolic genes. This produced an initial list of candidate genes that could be implicated in the metabolism of CFT073 in the urinary tract, but have not yet been characterised. This set of genes was inspected manually for those genes which appeared to have a metabolic function from their GenBank annotation [11], but without a definite, specific biological function, henceforth referred to as putatively metabolic genes (PMGs).

Where there was a PMG surrounded by uncharacterised genes, this region of the genome sequence was viewed using the NCBI's Sequence Viewer 2.1 and all adjacent genes transcribed in the same direction as the PMG and less than 100 base pairs separated were labelled as part of a Set of Adjacent Colinear genes (SAC) and included in the analysis. The algorithm for inferring whether a SAC was present in each of the Escherichia genomes considered was as follows: where the SAC was greater than 3 genes in length it was considered present if at most one of the genes was absent according to the synteny comparison; where there were 3 or fewer genes, all genes had to be present to conclude that the set of genes was present.

BLASTp was then used on each gene in the SACs against the full nonredundant database of Genbank [14] to try to find homologies to already annotated genes. Where homologs could not be found, protein domain similarities were sought using Pfam [15] and SEED ( in an endeavour to elucidate their function. Further, the NCBI's Conserved Domain Database was searched for conserved domains. The results of the Conserved Domain Database searches can be seen in Supplementary Table 2 in supplementary matarial available online at

A phylogenetic comparison between the putative L-sorbose operons from those sequenced bacteria of the genus Escherichia, using Klebsiella pneumoniae (GI: 150953431) and Klebsiella oxytoca (see acknowledgments for reference) as an outgroup, was conducted using ClustalX [16]. BLAST was used to extract the putative L-sorbose operons for most of the bacteria, but Artemis [17] was required to extract the relevant parts of both the Klebsiella strains and F11, which do not yet have complete single contig genome sequences.

2.2. Experimental Verification of Putative Functions of Genes c4981 to c4987 from Escherichia coli CFT073

Escherichia coli strain DH5 was used as the test host for L-sorbose growth as it is known not to grow on L-sorbose and is designed to be highly competent. The genotype of DH5 is: fhuA2 (lacZ-argF)U169 80dlacZ M15 endA1 hsdR17 deoR nupG thi-1 supE44 gyrA96 relA1 recAI phoA .

The putative L-sorbose operon identified in CFT073 was excised using the forward and reverse primers -GCCAGCGACATGCAGAGTTAAGTAGCGCGA-3 and -AAATCTCCTGTAAAACGCGGAATATACC-3, respectively. The consequent 7.5 kb fragment was amplified using these primers with Phusion DNA polymerase (Finnzyme) and cloned into the pSC-B plasmid (Stratagene). The consequent construct was transformed into DH5 and bacteria with a correctly inserted plasmid were selected by blue/white screening on 100  g ml-1 ampicillin, 40  g ml-1 X-Gal, 20  g ml-1 IPTG plates and were picked off and spread onto a Nutrient Broth 2 (Oxoid) plate with 100  g ml-1 ampicillin to produce single colonies. The insertion and orientation were confirmed by sequencing from the M13 primers to be as shown in Figure 1 and the plasmid was named pQR793.

One colony was then picked from the Nutrient Broth 2 plate and grown in 5 mL of a modified liquid M6 medium (5 20 gl-1 (NH4)2 SO4, 3.86 gl−1 NaH2PO4 H2O, 4.03 gl−1 KCl, 4.16 gl−1 Citric Acid, 1.04 gl−1 MgSO4 7H2O, 0.25 gl−1 CaCl2 2H2O, 20.6 mgl−1 ZnSO4 7H2O, 27.2 mgl−1 MnSO4 4H2O, 8.1 mgl−1 CuSO4 5H2O, 4.2 mgl−1 CoSO4 7H2O, 100.6 mgl−1 FeCl3 6H2O, 0.3 mgl−1 H3BO3, 0.2 mgl−1 Na4MoO4 2H2O adjusted to pH 7.3 by NaOH) with 1% glucose, 0.001% thiamine (a requirement for DH5 to grow) and 100  g ml−1 ampicillin; shaken at 150 rpm, 37°C overnight, then inoculated into two 100 mL shake flasks, one containing the same medium composition as the starter culture and the other containing 1% L-sorbose instead of glucose. Simultaneously DH5 with an empty pUC19 plasmid and CFT073 were grown in the same manner as negative and positive controls, respectively, (no ampicillin was used in the growth of CFT073 as it is not ampicillin resistant and selection is not required).

These flasks were shaken at 150 rpm at 37°C for 145 hours and samples were taken at intervals to measure optical density of the samples at wavelength 600 nm. Each culture was repeated twice to confirm the result growth or lack thereof.

3. Results and Discussion

3.1. Multiple Genome Comparison

The set of genome sequences used in this study will be referred to as the EGSS (Escherichia genome sequence set); the results of the complete synteny comparison of the genome of CFT073 against the rest of the EGSS can be seen in Supplementary Table 1.

Overall 133 PMGs were inferred; they can be seen in Supplementary Table 2, along with the results of the NCBI Conserved Domain Search, and are summarised in Table 2. All of the individual genes marked with putative metabolic functions in the CFT073 genome sequence were positioned adjacent to genes transcribed in the same sense, so the sets of adjacent colinear genes were included in the investigation, a summary of which can be seen in Table 2, and positions of which in the CFT073 genome can be seen in Figure 2. It should be emphasised that the criterion for consideration of these genes was only that the genes marked with putative functions be absent from E. coli K-12 MG1655, without any further consideration of whether they would specifically be useful in the lifecycle of CFT073. 9 of these genes are present in all of and only in the UPEC and 49 genes are among those identified by Lloyd et al. [18], which compared the gene content of 7 additional UPEC and 2 different faecal strains of E. coli by comparative genomic hybridisation against CFT073 to find those genes unique to uropathogens.

SAC no. Gene c numbersNo. of genes Putative functionE. coli F11E. coli 536E. coli UTI89E. coli E2348E. coli O42E. coli B171E. coli E24377AE. coli E22E. coli B7AE. coli E110019E. coli 53638S. sonnei 53GE. coli HSE. coli K12 MG1655E. coli O157H7E. coli O157:H7 EDL933  E. coli SMS-3-5S. flexneri 2a str. 201S. dysenteriae Sd197

1c0317 c03237Polysaccharide biosynthesis*
2c0330 c03334Fucose metabolism+++
3c0409 c041572,5-diketo-D-gluconic acid metabolism++++++
4c0757 c07659Chorismate biosynthesis++++
5c1955 c19606PTS system, cellobiose specific +++++++++
6c3405 c34106PTS system, maltose/glucose specific*+++++
7c3750 c375675- or 6-carbon sugar metabolism+++++
8c4013 c40186Carbohydrate metabolism+++
9c4276 c42805PTS system, galactitol specific++++++++
10c4481 c44888PTS system, fructose specific++++
11c4756 c47594PTS system, glucose specific++++
12c4760 c478021Entner-Doudoroff pathway+++
13c4828 c48303Shikimate metabolism+++++++
14c4924 c49263Citrate metabolism++++
15c4981 c49877L-sorbose metabolism++++++++++
16c5020 c502563-ketoacid metabolism+
17c5030 c5041122-oxoglutarate metabolism++++
18c5298 c530363-ketoacid metabolism++++++++++++
19c5346 c53515Arginine metabolism+++

The synteny comparison shows several characteristics indicating a higher prevalence of the genes from CFT073 in the other UPEC than in the other strains. It is worth noting that the sets of adjacent colinear genes identified in this study are not in general parts of the large pathogenicity islands identified in CFT073 by others [9, 18], with the exception of those marked with an asterisk in Table 2.

SAC No. 6 (as labelled in Table 2) is within a large pathogenicity island, PAI-CFT073-metV (according to the nomenclature set out by Lloyd et al. [18]), in which the SAC is restricted to the area c3405 to c3410. These genes are retained in all the UPEC, in E. coli E2348, and in E. coli SMS-3-5, but not in any other strain. Retention of the SorCDFBAME genes (SAC No. 15) in some of the EAEC and EPEC and all of the Shigella is consistent with the findings of Lehmacher and Bockemühl [12] who despite the negative phenotype showed that they retain the DNA for many of these genes.

It was found that 121 of the 133 PMGs identified are present in the same position in all four UPEC; these include the putative genes for L-sorbose degradation. The only SAC not present in any of the UPEC other than CFT073 is No. 1. Those found in the same place in all UPEC, but in none of the other strains, are 8, 12, and 19. The SACs identified here have a tendency to be present or absent as a whole, rather than on a gene-by-gene basis.

An investigation of each of the PMGs was conducted using BLAST, the SEED tool, Pfam, and the NCBI Conserved Domain Database, in an attempt to identify putative functions for all the genes. SAC No. 8 (genes c4013 to c4018) has several genes annotated putatively already, c4015 to c4017 as part of a ribose ABC transporter, and c4018 as a tagatose 1,6-diphosphate aldolase. The hypothetical genes bear similarities to other sugar metabolism encoding genes: c4013 to a dehydrogenase and c4014 to a sugar kinase, possibly a fructokinase. These genes could encode enzymes for the uptake and catabolism of a 5- or 6-carbon sugar or sugar derivative.

Since there is a limited number of carbon sources present in urine—predominantly urea, uric acid, and creatinine (and L-sorbose in small amounts)—it might seem plausible that the sets of genes identified here may encode proteins for the utilisation of these chemicals. However, an analysis of the genes investigated here has so far failed to find any good matches to known metabolic pathways for these three carbon containing compounds. UPEC are not confined to using the small molecule carbon sources in urine; they adhere primarily to the epithelial cells in the urinary tract so potentially the mucus produced by these cells could be used to fulfil the metabolic needs of UPEC.

The benefit of D-serine utilisation genes for UPEC has been suggested [4]; so these genes were investigated in the UPEC included in this study to assess their relative prevalence. It was noted that according to the initial synteny comparison (Supplementary Table 1), these genes are not present in E. coli F11 or 536. However, there are D-serine utilisation genes in both F11 and 536 at an alternative position in the genome identified by Brzuszkiewicz et al. [4]. Moreover, UTI89 also has D-serine utilisation genes in this alternative position on its genome as well as those found in this study. None of the non-UPEC in the EGSS have this alternative operon, which is characterised by a particularly large intergenic region ( 1 kb) adjacent to it, conserved between F11, 536 and UTI89. This D-serine utilisation operon is therefore unique within the strains considered here to the UPEC.

3.2. L-sorbose In Silico Analysis

L-sorbose [19] can be present in urine (and in the gastrointestinal tract). It can be seen from Table 2 that it is predominantly the UPEC and Shigella strains which contain the operon enabling use of L-sorbose as a carbon source.

The putative L-sorbose operon in CFT073 was compared to that of Klebsiella pneumoniae using BLASTp. Both of these strains are in the family Enterobacteriaceae and the function of Klebsiella's operon has been experimentally verified [20]. The results of this comparison are shown in Table 3, which shows identity above 90% for all but one of the genes.

CFT073 CFT073 nameKlebsiella nameKlebsiella Protein
gene ID Locus Similarity (%)

c4981 Putative oxidoreductase L-sorbose 1-phosphate reductaseSorE 91
c4982 PTS system, mannose-specific second subunit of EII-SorSorM 97
IID component
c4983 PTS system, mannose-specific first subunit of EII-SorSorA 95
IIC component

c4984 Putative sorbose PTS component EIII-B Sor PTSSorB 92
c4985 Putative sorbose PTS component EIII-F Sor PTSSorF 82
c4986 sorbitol-6-phosphate 2-dehydrogenase D-glucitol-6-P-DehydrogenaseSorD 92

c4987 Putative transcriptional regulator Sor regulatorSorC 92
of sorbose uptake and utilization genes

The ClustalX comparison of the putative sorbose operons of 13 strains of bacteria produced the phylogenetic tree shown in Figure 3. These bacteria are all of genus Escherichia (except the Klebsiella strains) and include several Shigella strains, Shigella boydii Sb227 (Accession Number: CP000036.1) and Shigella sonnei Ss046 (Accession Number: CP000038.1), not used in the full genome analysis because their genomes are not completely sequenced. The operons were located in the genome sequence thus far generated for them and extracted to compare to the others in the EGSS. Also included is the inferred L-sorbose operon from Avian Pathogenic Escherichia coli O1:K1:H7 (APEC 01) [21] (Accession Number: CP000468.1), which clusters with the UPEC, separate from the enterohaemorrhagic E. coli (EHEC) and Shigella strains. This is also true of the environmental E. coli SMS-3-5. The EHEC and Shigella L-sorbose operons are grouped together.

3.3. Experimental Verification of Function of Genes c4981 to c4987 from Escherichia coli CFT073

The genes c4981 to c4987 were successfully cloned into the pSC-B plasmid and confirmed by sequencing as being oriented as shown in Figure 1. The growth of the three strains in minimal media containing either glucose or L-sorbose as sole carbon source can be seen in Figure 4. The negative control, DH5 with pUC19, was unable to utilise this carbon source. DH5 containing the pQR793 plasmid grew using L-sorbose as the sole carbon source.

The functions of genes c4981 to c4987 from Escherichia coli CFT073 have therefore been confirmed as those encoding a pathway for the utilisation of L-sorbose as a sole carbon source. The nucleotide sequence identity between this operon (along its entire length) and the operon identified and experimentally characterised in Klebsiella pneumoniae [22] is 78%. Table 3 shows that all but one of the protein amino acid sequence differences between corresponding genes in these two operons are above 90%. These high similarities imply that not only do the two operons both utilise L-sorbose, but that the same pathway is used by both. The phylogenetic analysis of the L-sorbose operon conducted as part of this research shows how this operon fits in the phylogeny of L-sorbose operons in the genus Escherichia. The Glucitol-6-phosphate dehydrogenase found in Klebsiella pneumoniae has been shown to be temperature sensitive [20], which might account for the long lag phase and slow growth of DH5 containing the plasmid.

4. Conclusions

Multiple genome sequence analysis has been used to identify several sets of adjacent colinear genes in E. coli CFT073 that are not present in E. coli MG1655 and might be implicated in metabolism in the human urinary tract. Specifically a previously incompletely annotated operon encoding proteins involved in L-sorbose catabolism have been identified and experimentally confirmed encompassing genes c4981 to c4987 of the genome of uropathogenic Escherichia coli strain CFT073. The sets of genes from CFT073 found solely in UPEC include an arginine metabolic operon, which has previously been implicated in UPEC fitness in the urinary tract. The use of such sets of genomic data will become increasingly important as the rate of sequencing increases while experimental verification of gene function lags considerably behind. Although elucidation of novel gene function cannot be done purely through comparative genomics, it can aid searches for important genes, not necessarily previously characterised in other species or strains.


APEC:Avian pathogenic Escherichia coli
EGSS:Escherichia genome sequence set
HGT:Horizontal gene transfer
PMG:Putatively metabolic gene
PTS:Phosphotransferase transport system
UPEC:Uropathogenic Escherichia coli
UTI:Urinary tract infection.


This work was supported by the Biotechnology and Biological Sciences Research Council (UK). The sequence data for strains Escherichia coli O42, E2348, and Shigella sonnei 53G were produced by the Pathogen Sequencing Group at the Wellcome Trust Sanger Institute, were used with permission, and can be obtained from Klebsiella oxytoca's L-sorbose operon sequence was produced by the Genome Sequencing Center at Washington University School of Medicine in St. Louis and can be obtained from Klebsiella_oxytoca-1.0/output/.

Supplementary Materials

The supplementary spreadsheet file contains two worksheets. Supplementary Table 1 shows a list of genes in E. coli CFT073, referred to by both GI number (from Genbank) and c number (from the sequencing project), along with a gene label where this has been established. Each of the following columns indicates the presence or absence (by a 1 or 0 respectively) of that gene in the organism indicated at the top of the column, according to the synteny comparison undertaken in the accompanying paper. The three organisms highlighted in grey are the other uropathogenic E. coli included in the comparison.

Supplementary Table 2 lists the genes inferred in the acompanying paper to be candidates for metabolic functions that have not been fully characterised. Along with GI number and c number is the name given to the gene in the genome sequencing project. Presence or absence of each gene in the other E. coli in the comparison is indicated. Also shown are the data gathered from the Conserved Domains Database (NCBI), indicating potential functions for these genes.

  1. Supplementary Material


  1. A. Ronald, “The etiology of urinary tract infection: traditional and emerging pathogens,” Disease-a-Month, vol. 49, no. 2, pp. 71–82, 2003. View at: Publisher Site | Google Scholar
  2. L. Emődy, M. Kerényi, and G. Nagy, “Virulence factors of uropathogenic Escherichia coli,” International Journal of Antimicrobial Agents, vol. 22, supplement 2, pp. S29–S33, 2003. View at: Publisher Site | Google Scholar
  3. D. M. Gordon and M. A. Riley, “A theoretical and experimental analysis of bacterial growth in the bladder,” Molecular Microbiology, vol. 6, no. 4, pp. 555–562, 1992. View at: Google Scholar
  4. E. Brzuszkiewicz, H. Brüggemann, H. Liesegang et al., “How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 34, pp. 12879–12884, 2006. View at: Publisher Site | Google Scholar
  5. T. T. Binnewies, Y. Motro, P. F. Hallin et al., “Ten years of bacterial genome sequencing: comparative-genomics-based discoveries,” Functional and Integrative Genomics, vol. 6, no. 3, pp. 165–185, 2006. View at: Publisher Site | Google Scholar
  6. S. F. Altschul, T. L. Madden, A. A. Schäffer et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,” Nucleic Acids Research, vol. 25, no. 17, pp. 3389–3402, 1997. View at: Publisher Site | Google Scholar
  7. C. L. Barrett and B. O. Palsson, “Iterative reconstruction of transcriptional regulatory networks: an algorithmic approach,” PLoS Computational Biology, vol. 2, no. 5, article e52, 2006. View at: Publisher Site | Google Scholar
  8. S. M. Turner, R. R. Chaudhuri, Z.-D. Jiang et al., “Phylogenetic comparisons reveal multiple acquisitions of the toxin genes by enterotoxigenic Escherichia coli strains of different evolutionary lineages,” Journal of Clinical Microbiology, vol. 44, no. 12, pp. 4528–4536, 2006. View at: Publisher Site | Google Scholar
  9. R. A. Welch, V. Burland, G. Plunkett III et al., “Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 26, pp. 17020–17024, 2002. View at: Publisher Site | Google Scholar
  10. D. A. Rasko, M. J. Rosovitz, G. S. A. Myers et al., “The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates,” The Journal of Bacteriology, vol. 190, no. 20, pp. 6881–6893, 2008. View at: Publisher Site | Google Scholar
  11. National Institute of Health, “GenBank,” 2006, View at: Google Scholar
  12. A. Lehmacher and J. Bockemühl, “L-Sorbose utilization by virulent Escherichia coli and Shigella: different metabolic adaptation of pathotypes,” International Journal of Medical Microbiology, vol. 297, no. 4, pp. 245–254, 2007. View at: Publisher Site | Google Scholar
  13. V. Roos, G. C. Ulett, M. A. Schembri, and P. Klemm, “The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine,” Infection and Immunity, vol. 74, no. 1, pp. 615–624, 2006. View at: Publisher Site | Google Scholar
  14. D. A. Benson, I. Karsch-Mizrachi, D. J. Lipman, J. Ostell, and D. L. Wheeler, “GenBank,” Nucleic Acids Research, vol. 35, pp. 21–25, 2007. View at: Google Scholar
  15. A. Bateman, L. Coin, R. Durbin et al., “The Pfam protein families database,” Nucleic Acids Research, vol. 32, pp. D138–D141, 2004. View at: Google Scholar
  16. J. D. Thompson, T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins, “The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools,” Nucleic Acids Research, vol. 25, no. 24, pp. 4876–4882, 1997. View at: Publisher Site | Google Scholar
  17. K. Rutherford, J. Parkhill, J. Crook et al., “Artemis: sequence visualization and annotation,” Bioinformatics, vol. 16, no. 10, pp. 944–945, 2000. View at: Google Scholar
  18. A. L. Lloyd, D. A. Rasko, and H. L. T. Mobley, “Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli,” The Journal of Bacteriology, vol. 189, no. 9, pp. 3532–3546, 2007. View at: Publisher Site | Google Scholar
  19. D. S. Wishart, D. Tzur, C. Knox et al., “HMDB: the human metabolome database,” Nucleic Acids Research, vol. 35, pp. 521–526, 2007. View at: Publisher Site | Google Scholar
  20. G. A. Sprenger and J. W. Lengeler, “L-Sorbose metabolism in Klebsiella pneumoniae and Sor+ derivatives of Escherichia coli K-12 and chemotaxis toward sorbose,” The Journal of Bacteriology, vol. 157, no. 1, pp. 39–45, 1984. View at: Google Scholar
  21. T. J. Johnson, S. Kariyawasam, Y. Wannemuehler et al., “The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes,” The Journal of Bacteriology, vol. 189, no. 8, pp. 3228–3236, 2007. View at: Publisher Site | Google Scholar
  22. G. A. Sprenger and J. W. Lengeler, “Mapping of the sor genes for L-sorbose degradation in the chromosome of Klebsiella pneumoniae,” Molecular & General Genetics, vol. 209, no. 2, pp. 352–359, 1987. View at: Publisher Site | Google Scholar

Copyright © 2009 William A. Bryant et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.